Insider filing · ALNY
Michael W Bonney
Director
profile →
Alnylam Pharmaceuticals, Inc.
ALNY · Healthcare · 56 filings in 24 months
ticker →
Michael W Bonney sold $3.0M of Alnylam Pharmaceuticals (ALNY)
Executed May 15 2025, disclosed May 19 2025, 4 days later.
Value, as filed
$3.0M
10,704 sh across 12 lots
Executed
May 15 2025
the trade date, as filed
Disclosed
May 19 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MBMichael W Bonney (Director) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in Alnylam Pharmaceuticals, Inc. (ALNY). The largest single filing was $5.1M of ALNY (11,250 sh × $450.00, as filed), executed Aug 18 2025.
The name
ALNYHealthcare · Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Michael W Bonney in ALNY
ALNYSALE
Alnylam Pharmaceuticals, Inc.
$5.1M11,250 sh × $450.00
Exec Aug 18 2025
Filed Aug 19 2025 · 5:30 PM ET